In Stock, Ready to Ship!
Original price was: $130.00.$115.00Current price is: $115.00. — or subscribe and save 20%
99% Pure | USA Made | Multi DoseThymosin Alpha 1 (TA1) is a powerful immune-modulating peptide studied for its ability to activate T-cells, regulate inflammation, and support recovery in viral, bacterial, and autoimmune conditions. Derived from the thymus gland, TA1 is a naturally occurring peptide fragment that plays a key role in immune system optimization. TA1 is used extensively in international research for conditions involving immune dysfunction, including cancer, chronic infections, and autoimmune disease models. Our 10mg lyophilized vial of TA1 is prepared under sterile conditions and is intended strictly for research use.
Peptides are not ready to use. Must purchase BAC water for reconstitution.
Each vial of Retatrutide undergoes stringent quality control measures to meet the highest research standards. It is lab-tested for purity, potency, and consistency, with a certificate of analysis (COA) provided for every batch. With a purity exceeding 99%, this lyophilized peptide powder is ideal for controlled research environments that demand reliable and repeatable results.
Retatrutide is a cutting-edge tri-agonist peptide that is transforming the field of metabolic research. Designed to simultaneously activate the GLP-1, GIP, and GCGR (glucagon) receptors, this multifunctional peptide offers a more comprehensive and synergistic approach to modulating appetite, enhancing insulin function, and accelerating fat metabolism.
What sets Retatrutide apart from traditional single-pathway compounds like semaglutide is its ability to address multiple metabolic pathways at once, making it highly attractive for advanced obesity, diabetes, and longevity studies.
Retatrutide is a research-grade peptide known for its tri-agonist activity—activating GLP-1, GIP, and glucagon receptors simultaneously. It is being studied in scientific settings for its unique mechanism of action across metabolic pathways.
No. Retatrutide is a synthetic peptide, engineered in laboratory settings to mimic and enhance the function of naturally occurring hormonal pathways in research models.
Retatrutide is commonly studied in metabolic, obesity, glucose regulation, and energy balance models. Its triple-receptor profile makes it an ideal candidate for preclinical exploration of multi-receptor metabolic interactions.
Research protocols often begin with 0.25mg and may scale to 0.5mg or 1mg, depending on the experimental model and study goals. Dosage should be determined based on internal SOPs and protocol requirements.
Yes. Dosage charts for Retatrutide are typically created based on model weight, study length, and receptor activation goals. Charts often show titration schedules from 0.25mg up to 1mg over several weeks.
Yes. Retatrutide is frequently used in research stacks with peptides such as Tesamorelin, CJC-1295, or Cagrilintide to explore synergistic effects in metabolic modeling.
No. Retatrutide is classified as a triple agonist, meaning it activates GLP-1, GIP, and GCGR receptors, offering a broader biological profile for researchers studying complex peptide interactions.
Lyophilized Retatrutide should be stored at or below -20°C for long-term stability. After reconstitution, storage in a refrigerated environment is generally recommended as per research protocols.
No. Retatrutide is not approved by the FDA and is sold strictly for laboratory and research purposes only. It is not intended for human or veterinary use.
Our Retatrutide is USA-manufactured under cGMP-like conditions, with each batch lab-tested for purity, potency, and consistency. Certificates of Analysis (COA) are provided for all research peptides.
Don't hestitate to contact us
End of Content.
